Anthony Buisson
0000-0002-6347-409X
72 papers found
Refreshing results…
Variation of faecal calprotectin level within the first three months after bowel resection is predictive of endoscopic postoperative recurrence in Crohn's disease
Efficacy of Tumor Necrosis Factor Antagonist Treatment in Patients With Refractory Ulcerative Proctitis
Monitoring a Combination of Calprotectin and Infliximab Identifies Patients With Mucosal Healing of Crohn’s Disease
Association Between Microscopic Lesions at Ileal Resection Margin and Recurrence After Surgery in Patients With Crohn’s Disease
Systematic review and external validation of prediction models based on symptoms and biomarkers for identifying endoscopic activity in Crohn's disease
Oral Curcumin No More Effective Than Placebo in Preventing Recurrence of Crohn's Disease After Surgery in a Randomized Controlled Trial
Prominence of ileal mucosa-associated microbiota to predict postoperative endoscopic recurrence in Crohn’s disease
Combined evaluation of biomarkers as predictor of maintained remission in Crohn’s disease
Rapid Desensitization to Adalimumab Is Associated With Decreased Basophil Sensitivity
Metabolic adaptation of adherent-invasive Escherichia coli to exposure to bile salts
T cell clonal expansions in ileal Crohn's disease are associated with smoking behaviour and postoperative recurrence
Faecal calprotectin is a very reliable tool to predict and monitor the risk of relapse after therapeutic de-escalation in patients with inflammatory bowel diseases
Bowel cleansing in IBD: When acceptability means efficacy. . .,Préparation colique dans les MICI: Quand acceptabilité rime avec efficacité. . .
Three-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multi-centre cohort study
Adalimumab for patients with Crohn's disease complicated by intra-abdominal abscess: a multicentre, prospective, observational cohort study
Is fecal microbiota transplantation following vancomycin better than fidaxomicin to treat recurrent Clostridium difficile infection?,La séquence vancomycinetransplantation de microbiote fécal mieux que la fidaxomycine dans l'infection récidivante à Clostridium difficile ?
Bowel wall healing assessed using magnetic resonance imaging predicts sustained clinical remission and decreased risk of surgery in Crohn’s disease
Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, and Corticosteroid-Free Remission in Patients With Active Luminal Crohn’s Disease
IBD-INFO Questionnaire: A Multicenter French Up-to-Date Survey of Patient Knowledge in Inflammatory Bowel Disease
Fecal Calprotectin in Assessing Endoscopic and Histological Remission in Patients with Ulcerative Colitis
Missing publications? Search for publications with a matching author name.